Hepatitis B immunoglobulin in combination with lamivudine for prevention of hepatitis B virus reactivation in children undergoing bone marrow transplantation

Pediatric Transplantation

Volumn 10, Issue 8, 2006, Pages 966-969

  Tavil, Betul ^a   Kuşkonmaz, Bariş ^a   Kasem, Muhammed ^a   Demir, Hulya ^a   Çetin, Mualla ^a   Uçkan, Duygu ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

Author keywords

Bone marrow transplantation; Children; Hepatitis B immunoglobulin

Indexed keywords

BUSULFAN; CD45 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; LAMIVUDINE; METHOTREXATE; METHYLPREDNISOLONE; RECOMBINANT HEPATITIS B VACCINE; VIRUS DNA;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANAMNESIS; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DRUG ACTIVITY; DRUG MECHANISM; FEMALE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEPATITIS B; HEPATITIS B VIRUS; HLA MATCHING; HUMAN; MALE; ORGAN DONOR; PRESCHOOL CHILD; SCHOOL CHILD; THALASSEMIA MAJOR; VACCINATION; VIREMIA; VIRUS REACTIVATION;

BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; DRUG THERAPY, COMBINATION; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; IMMUNOGLOBULINS; IMMUNOLOGIC FACTORS; LAMIVUDINE; LEUKEMIA, MYELOID, CHRONIC; MALE; MIDDLE AGED; RECURRENCE; REVERSE TRANSCRIPTASE INHIBITORS; TRANSPLANTATION, HOMOLOGOUS; VIRUS ACTIVATION;

EID: 33750590617     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2006.00570.x     Document Type: Article

References (14)

1. REED EC, MYERSON D, COREY L, MEYERS JD. Allogeneic marrow transplantation in patients positive for hepatitis B surface antigen. Blood 1991: 77: 195-200.
2. PARIENTE EA, GOUDEAU A, DUBOIS F, et al. Fulminant hepatitis due to reactivation of chronic hepatitis B virus infection after allogeneic bone marrow transplantation. Dig Dis Sci 1988: 33: 1185-1191.
3. WEBSTER A, BRENNER MK, PRENTICE HG, GRIFFITHS PD. Fatal hepatitis B reactivation after autologous bone marrow transplantation. Bone Marrow Transplant 1989: 4: 207-208.
4. FAN FS, TZENG CH, YEH HM, CHEN PM. Reverse seroconversion of hepatitis B virus infectious status after allogeneic bone marrow transplantation from a carrier donor. Bone Marrow Transplant 1992: 10: 189-191.
5. DUMORTIER J, CHEVALLIER P, SCOAZEC JY, BERGER F, BOILLOT O. Combined lamivudine and hepatitis B immunoglobulin for the prevention of hepatitis B recurrence after liver transplantation: long-term results. Am J Transplant 2003: 3: 999-1002.
6. HASHINO S, NOZAWA A, IZUMIYAMA K, et al. Lamivudine treatment for reverse seroconversion of hepatitis B 4 years after allogeneic bone marrow transplantation. Bone Marrow Transplant 2002: 29: 361-363.
7. CASELITZ M, LINK H, HEIN R, et al. Hepatitis B associated liver failure following bone marrow transplantation. J Hepatol 1997: 27: 572-577.
8. MARTIN BA, ROWE JM, KOUIDES PA, DIPERSIO JF. Hepatitis B reactivation following allogeneic bone marrow transplantation: Case report and review of the literature. Bone Marrow Transplant 1995: 15: 145-148.
9. IWAI K, TASHIMA M, ITOH M, et al. Fulminant hepatitis B following bone marrow transplantation in an HBsAg-negative, HBsAb-positive recipient; reactivation of dormant virus during the immunosuppressive period. Bone Marrow Transplant 2000: 25: 105-108.
10. KUPELI S, OZEN H, UCKAN D, et al. Changes in hepatitis B virus serology in bone marrow transplanted children. Pediatr Transplant 2002: 6: 406-410.
11. LAU GK, SURI D, LIANG R, et al. Resolution of chronic hepatitis B and anti-HBs seroconversion in humans by adoptive transfer of immunity to hepatitis B core antigen. Gastroenterology 2002: 122: 614-624.
12. CHISARI FV, FERRARI C. Hepatitis B virus immunopathogenesis. Annu Rev Immunol 1995: 13: 29-60.
13. DOONG L, TSAI H, SCHINAZI F. Inhibition of the replication of hepatitis B virus in vitro by 2-3-dideoxy-3-thiacytidine and related analogues. Proc Natl Acad Sci USA 1991: 88: 8495-8499.
14. IRINONDO A, PASTOR JM, HERMOSA V, et al. Protection against hepatitis B after marrow transplantation. Ann Intern Med 1986: 105: 293-294.